Bioatla, INC DEF 14A proxy statements

BioAtla, Inc. has announced its 2026 Annual Meeting of Stockholders, scheduled for July 16, 2026, to be held virtually, with key proposals including director elections and executive compensation.

BioAtla, Inc. has reconvened its special stockholders meeting on January 26, 2026, to vote on a reverse stock split proposal, following an initial failure to secure sufficient votes.

BioAtla, Inc. has adjourned its special stockholder meeting to January 12, 2026, to allow more time for voting on a proposed reverse stock split.

BioAtla, Inc. calls a Special Meeting to vote on issuing new shares for capital and a reverse stock split to maintain its Nasdaq listing.

BioAtla, Inc. has filed a definitive proxy statement with the SEC regarding its upcoming shareholder meeting.

BioAtla, Inc. will hold its 2025 Annual Meeting of Stockholders virtually on June 18, 2025, to vote on the election of directors, ratification of the independent accounting firm, and executive compensation.

BioAtla, Inc. has filed a definitive proxy statement with the Securities and Exchange Commission.

BioAtla, Inc. will hold its 2024 Annual Meeting of Stockholders virtually on June 13, 2024, to vote on the election of a director, ratification of the independent auditor, and executive compensation.